common side effects of atripla
dizziness
insomnia
skin rash
other side effects
drowsiness
lack of concentration
abnormal dreams
comprehensive list of adverse effects
common side effects
drug
psychiatric disorders
nervous system disorders
gastrointestinal disorders
clinical trial
individual components
common side effects
diarrhea
nausea
headache
fatigue
dizziness
depression
insomnia
abnormal dreams
rash
common side effects
efavirenz in combination with other antiretroviral drugs
least moderate severity
rash
dizziness
nausea
headache
fatigue
significant side effects
nervous system symptoms
psychiatric symptoms
rash
common side effects
emtricitabine in combination with other antiretroviral drugs of mild
moderate severity
headache
diarrhea
nausea
rash
asymptomatic skin discoloration
hyperpigmentation on the palms
soles
emtricitabine than the control treatment
common side effects
tenofovir in combination with other antiretroviral drugs
moderate gastrointestinal events
including nausea
diarrhea
vomiting
flatulence
elevated fasting cholesterol
mg/dl
elevated fasting triglycerides
mg/dl
altered serum glucose
mg/dl
mg/dl
hyperglycemia
mg/dl
elevated alkaline phosphatase
units/l
patients
hypercholesterolemia
hypertriglyceridemia
postmarketing experience with efavirenz
lactic acidosis
steatosis
including
fatal cases
use of nucleoside analogs
hypokalemia
hypophosphatemia
result of proximal renal tubulopathy
hypokalemia
lactic acidosis
hypophosphatemia
postmarketing experience with tenofovir
elevated fasting cholesterol
anorexia
elevated fasting triglycerides
altered serum glucose
hyperglycemia
elevated alkaline phosphataseuncommon
increased appetiteefavirenz
anorexia
hypercholesterolemia-postmarketing reports
redistribution/accumulation of body fat
areas
back of neck
breasts
abdomen
retroperitoneum
emtricitabine
hyperglycemia
hypertriglyceridemiatenofovir
hypophosphatemia-uncommon
hypokalemia-rare
lactic acidosiscombination
antiretroviral therapy
frequency
metabolic abnormalities
hypertriglyceridemia
hypercholesterolemia
insulin resistance
hyperglycemia
hyperlactatemia
redistribution/accumulation of body fat
including
central obesity
dorsocervical fat enlargement
peripheral wasting
facial wasting
breast enlargement
cushingoid appearance
diarrhea
nausea
elevated serum amylase
vomitinguncommon
dry mouthemtricitabine
tenofovir
dyspepsia
abdominal pain
elevated pancreatic amylase
elevated serum lipaseefavirenz
dyspepsia
abdominal pain
diarrhea
vomiting
pancreatitis-postmarketing reports
constipation
malabsorptionemtricitabine
diarrhea
elevated amylase
including
elevated pancreatic amylase
elevated serum lipase
vomiting
abdominal pain
dyspepsiatenofovir
diarrhea
vomiting
abdominal pain
abdominal distension
pancreatitis-postmarketing reports
increased amylase
elevated serum amylase
units/l
patients
elevated pancreatic amylase
uln
serum lipase
uln
emtricitabine
tenofovir
patients
pancreatitis
abdominal pain
postmarketing experience with efavirenz
tenofovir
serious psychiatric side effects
efavirenz
severe depression
suicidal ideation
nonfatal suicide attempts
aggression
paranoia
mania
aggression
agitation
lability
psychosis
paranoia
mania
postmarketing experience with efavirenz
depression
anxiety
insomniauncommon
decreased libidoefavirenz
insomnia
depression
anxiety
severe depression
abnormal dreams
nervousness
hallucination-uncommon
suicidal ideation
nonfatal suicide attempts
aggression
paranoia
mania
psychosis
euphoric mood
affect/emotional lability
confusional state
agitation-frequency
depersonalization
delirium-postmarketing reports
delusions
neurosis
psychosis-like behavior
completed suicideemtricitabine
insomnia
abnormal dreams
dizziness
headacheuncommon
incoherent speechemtricitabine
tenofovir
paresthesia
peripheral neuropathy
including
peripheral neuritis
neuropathy
efavirenz
nervous system symptoms
dizziness
impaired concentration
somnolence
cerebellar coordination
balance disturbances
headache
disturbance in attention-uncommon
convulsions
amnesia
abnormal thinking
ataxia
abnormal coordination
tremor
vertigo
tinnitus-frequency
stupor-postmarketing reports
hypoesthesia
paresthesia
neuropathyemtricitabine
headache-common
dizzinesstenofovir
dizziness-common
headache
nervous system symptoms of any grade
causality
dizziness
insomnia
impaired concentration
somnolence
abnormal dreams
hallucinations
amnesia
agitation
euphoria
depersonalization
confusion
abnormal thinking
stupor during clinical trials of efavirenz in combination with other antiretroviral agents
symptoms
patients
second day of therapy
weeks
therapy
patients
side effects
abnormal coordination
ataxia
cerebellar coordination
balance disturbances
convulsions
tremor
tinnitus
vertigo
postmarketing experience with efavirenz
rashes
efavirenz
mild-to-moderate maculopapular skin eruptions
median time
onset of rash
days
most patients
therapy
rash
month
treatment
patients
rash
limited experience
using efavirenz in patients
discontinued other nonnucleoside reverse transcriptase inhibitors
rash
such patients
nevirapine
half
moderate rash
patients
discontinued efavirenz
rash
erythema multiforme
pruritus
photoallergic dermatitis
stevens-johnson syndrome
postmarketing experience with efavirenz
rash
postmarketing experience with tenofovir
rash event
including rash
exfoliative rash
generalized rash
macular rash
maculopapular rash
pruritic rash
vesicular rash
emtricitabine
tenofovir
rash event
including rash
pruritus
maculopapular rash
urticaria
vesiculobullous rash
pustular rash
allergic reaction
efavirenz
skin rash of any grade
grade rash
diffuse maculopapular rash
dry desquamation
grade rash
erythema
pruritus
pruritus-uncommon
grade rash
vesiculation
moist desquamation
ulceration
grade rash
erythema multiforme
stevens-johnson syndrome
toxic epidermal necrolysis
necrosis
requiring surgery
exfoliative dermatitis
photoallergic dermatitis-frequency
disorders
skin discoloration
leukocytoclastic vasculitisemtricitabine
vesiculobullous rash
pustular rash
maculopapular rash
rash
pruritus
urticaria
skin discoloration
palmar-plantar hyperpigmentation
postmarketing reports
angioedematenofovir
rash-rare
angioedema
fatiguefrequency
increased body weightemtricitabine
tenofovir
fever
pain
painefavirenz
pain
fatigue-uncommon
flushing-frequency
false-positive urine cannabinoid test
results-postmarketing reports
contraceptive failure
implantable hormonal contraceptive
astheniaemtricitabine
pain
astheniatenofovir
asthenia-frequency
vitamin d levels
false-positive urine cannabinoid test results
screening assays in uninfected
hiv-infected patients
receiving efavirenz
flushing
asthenia
postmarketing experience with efavirenz
tenofovir
sinusitis
upper respiratory tract infections
nasopharyngitisemtricitabine
tenofovir
increased cough
pneumonia
rhinitisefavirenz
postmarketing reports
dyspneatenofovir
postmarketing reports
dyspnea
elevated ast
units/l in males
units/l in females
alt
units/l in males
units/l in females
patients
ast
alt elevations
patients
hepatitis b
c
patients without coinfection
elevated bilirubin
times
upper limit of normal
uln
emtricitabine
tenofovir
patients
severe acute exacerbations of hepatitis b
patients
hiv
hepatitis b after discontinuation of emtricitabine
tenofovir
liver failure
liver decompensation in some of the emtricitabine-treated patients
postmarketing reports of hepatic failure with efavirenz
patients with no
preexisting liver disease
other identifiable risk factors
lactic acidosis
steatosis
including
fatal cases
nucleoside analogs
hepatic steatosis
hepatitis
postmarketing experience with tenofovir
elevated ast
elevated altemtricitabine
tenofovir
elevated bilirubin-frequency
severe acute exacerbations of hepatitis befavirenz
elevated alt
elevated ast
elevated ggt-uncommon
acute hepatitis-postmarketing reports
hepatic enzyme increase
hepatic failure
few reports
fulminant course
cases
transplantation
death
hepatitisemtricitabine
elevated serum ast
elevated serum alt
hyperbilirubinemia-frequency
liver failure
liver decompensationtenofovir
hepatic steatosis
hepatitis-frequency
lactic acidosis/severe hepatomegaly with steatosis-postmarketing reports
elevated liver enzymes
ast
alt
ggt
decreased neutrophils
mm
patients
decreased neutrophilsfrequency
increased hemoglobinemtricitabine
neutropenia-uncommon
anemia
elevated creatine kinase
units/l in males
units/l in females
patients
rhabdomyolysis
osteomalacia
muscular weakness
myopathy
result of proximal renal tubulopathy
rhabdomyolysis
osteomalacia
muscular weakness
myopathy
postmarketing experience with tenofovir
elevated creatine kinaseuncommon
myalgiaemtricitabine
tenofovir
arthralgia
myalgiaemtricitabine
elevated creatine kinaseefavirenz
postmarketing reports
arthralgia
myalgia
myopathytenofovir
rhabdomyolysis
myopathy
osteomalacia
bone pain
contributing
fractures
frequency
decreased bone mineral density
biochemical markers of bone metabolismcombination
antiretroviral therapy
frequency
osteonecrosis
hematuriauncommon
glycosuriatenofovir
proteinuria-postmarketing reports
polyuria
hematuria
red blood cells/high power field
glycosuria
patients
proteinuria
postmarketing experience with tenofovir
tenofovir
increased creatinine-rare
renal failure
acute tubular necrosis
proximal renal tubulopathy
including
fanconi syndrome
nephrogenic diabetes insipidus-frequency
new onset
worsening
worsening renal impairment-postmarketing reports
renal insufficiency
nephritis
including
acute interstitial nephritis
rhabdomyolysis
osteomalacia
hypokalemia
muscular weakness
myopathy
hypophosphatemia
result of proximal renal tubulopathy
renal failure
acute renal failure
fanconi syndrome
proximal renal tubulopathy
creatinine
acute tubular necrosis
nephrogenic diabetes insipidus
postmarketing experience with tenofovir
frequency
immune reconstitution/reactivation syndrome
autoimmune disorders in the setting of immune reconstitution
graves
disease
polymyositis
guillain-barre syndrome
efavirenz
postmarketing reports
immune reconstitution syndromeemtricitabine
postmarketing reports
immune reconstitution syndrometenofovir
postmarketing reports
immune reconstitution syndrome
efavirenz
hypersensitivity-postmarketing reports
allergic reactionsemtricitabine
allergic reactiontenofovir
postmarketing reports
allergic reaction
including angioedema
efavirenz
frequency
qt interval prolongation
torsades de pointes-postmarketing reports
palpitations
efavirenz
gynecomastiatenofovir
frequency
higher serum
parathyroid hormone levels
gynecomastia
postmarketing experience with efavirenz
efavirenz
blurred vision-postmarketing reports
abnormal vision
blurred vision
postmarketing experience with efavirenz
stomach pain
tenderness
blistering
peeling
loosening of the skin
body aches
pain
clay-colored stools
cough
dark urine
ear congestion
fever or chills
headache
itching
loss of voice
muscle aches
nausea and vomiting
severe skin rash
sore throat
swelling of the feet
lower legs
tightness of the chest
trouble concentrating
yellow eyes
skin
diarrhea
dizziness
unusual tiredness
weakness
abnormal dreams
decreased appetite
discouragement
feeling
irritability
loss of appetite
loss of interest
pleasure
mild rash
pain
tenderness around the eyes
cheekbones
sleepiness
trouble sleeping
unusual drowsiness